Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-29 Option Award |
2022-06-30 4:19 pm |
N/A 2032-06-28 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Levy Richard S Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2022-06-29 Option Award |
2022-06-30 4:18 pm |
N/A 2032-06-28 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Popovits Kimberly J Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2022-06-29 Option Award |
2022-06-30 4:17 pm |
N/A 2032-06-28 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Cole G Bradley Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2022-06-29 Option Award |
2022-06-30 4:00 pm |
N/A 2032-06-28 |
Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director |
70,000 | $0 | 2,800,277 (Indirect) |
View |
| 2022-04-26 Exercise |
2022-04-28 4:31 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
991 | $0 | 9,328 (Direct) |
View |
| 2022-04-26 Tax Withholding |
2022-04-28 4:31 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
282 | $9.99 | 9,328 (Direct) |
View |
| 2022-04-07 Option Award |
2022-04-11 4:32 pm |
N/A 2032-04-06 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER |
69,920 | $0 | 69,920 (Direct) |
View |
| 2022-04-07 Option Award |
2022-04-11 4:31 pm |
N/A 2032-04-06 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER |
76,325 | $0 | 76,325 (Direct) |
View |
| 2022-04-07 Option Award |
2022-04-11 4:31 pm |
N/A 2032-04-06 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER |
47,190 | $0 | 47,190 (Direct) |
View |
| 2022-04-07 Option Award |
2022-04-11 4:30 pm |
N/A 2032-04-06 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO |
279,762 | $0 | 279,762 (Direct) |
View |
| 2022-04-07 Option Award |
2022-04-11 4:30 pm |
N/A 2032-04-06 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
69,368 | $0 | 69,368 (Direct) |
View |
| 2022-04-07 Option Award |
2022-04-11 4:30 pm |
N/A 2032-04-06 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
75,437 | $0 | 75,437 (Direct) |
View |
| 2022-03-21 Exercise |
2022-03-23 4:30 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO |
18,555 | $0 | 210,887 (Direct) |
View |
| 2022-03-21 Tax Withholding |
2022-03-23 4:30 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO |
5,446 | $10.98 | 210,887 (Direct) |
View |
| 2022-03-21 Exercise |
2022-03-23 4:30 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
2,270 | $0 | 7,372 (Direct) |
View |
| 2022-03-21 Tax Withholding |
2022-03-23 4:30 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
1,240 | $10.98 | 7,372 (Direct) |
View |
| 2022-03-21 Exercise |
2022-03-23 4:30 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
3,019 | $0 | 5,648 (Direct) |
View |
| 2022-03-21 Tax Withholding |
2022-03-23 4:30 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
1,047 | $10.98 | 5,648 (Direct) |
View |
| 2022-03-21 Exercise |
2022-03-23 4:30 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER |
5,676 | $0 | 35,117 (Direct) |
View |
| 2022-03-21 Tax Withholding |
2022-03-23 4:30 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER |
1,686 | $10.98 | 35,117 (Direct) |
View |
| 2022-03-21 Exercise |
2022-03-23 4:30 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER |
3,231 | $0 | 6,041 (Direct) |
View |
| 2022-03-21 Tax Withholding |
2022-03-23 4:30 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER |
1,120 | $10.98 | 6,041 (Direct) |
View |
| 2022-03-21 Exercise |
2022-03-23 4:30 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER |
4,611 | $0 | 112,213 (Direct) |
View |
| 2022-03-21 Tax Withholding |
2022-03-23 4:30 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER |
1,461 | $10.98 | 112,213 (Direct) |
View |
| 2022-03-16 Exercise |
2022-03-18 4:40 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R Chief Accounting Officer |
775 | $0 | 6,253 (Direct) |
View |
| 2022-01-15 Option Award |
2022-03-18 4:40 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R Chief Accounting Officer |
653 | $9.63 | 6,253 (Direct) |
View |
| 2020-06-30 Option Award |
2022-03-18 4:40 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R Chief Accounting Officer |
641 | $9.51 | 6,253 (Direct) |
View |
| 2021-07-15 Option Award |
2022-03-18 4:40 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R Chief Accounting Officer |
588 | $11.49 | 6,253 (Direct) |
View |
| 2022-03-16 Tax Withholding |
2022-03-18 4:40 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R Chief Accounting Officer |
269 | $10.13 | 6,253 (Direct) |
View |
| 2020-12-31 Option Award |
2022-03-18 4:40 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R Chief Accounting Officer |
405 | $15.02 | 6,253 (Direct) |
View |
| 2022-03-16 Exercise |
2022-03-18 4:39 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross Chief Commercial Officer |
995 | $0 | 9,324 (Direct) |
View |
| 2022-01-15 Option Award |
2022-03-18 4:39 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross Chief Commercial Officer |
1,546 | $9.63 | 9,324 (Direct) |
View |
| 2021-07-15 Option Award |
2022-03-18 4:39 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross Chief Commercial Officer |
963 | $11.49 | 9,324 (Direct) |
View |
| 2022-03-16 Tax Withholding |
2022-03-18 4:39 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross Chief Commercial Officer |
544 | $10.13 | 9,324 (Direct) |
View |
| 2022-03-16 Exercise |
2022-03-18 4:39 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. Chief Medical Officer |
1,725 | $0 | 36,302 (Direct) |
View |
| 2022-03-16 Tax Withholding |
2022-03-18 4:39 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. Chief Medical Officer |
598 | $10.13 | 36,302 (Direct) |
View |
| 2022-03-16 Exercise |
2022-03-18 4:38 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K Chairman & CEO |
6,569 | $0 | 217,485 (Direct) |
View |
| 2022-03-16 Tax Withholding |
2022-03-18 4:38 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K Chairman & CEO |
1,922 | $10.13 | 217,485 (Direct) |
View |
| 2022-03-16 Exercise |
2022-03-18 4:38 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark Chief Financial Officer |
872 | $0 | 6,292 (Direct) |
View |
| 2022-03-16 Tax Withholding |
2022-03-18 4:38 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark Chief Financial Officer |
303 | $10.13 | 6,292 (Direct) |
View |
| 2022-03-16 Exercise |
2022-03-18 4:36 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben Chief Operating Officer |
1,964 | $0 | 114,955 (Direct) |
View |
| 2022-01-15 Option Award |
2022-03-18 4:36 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben Chief Operating Officer |
970 | $9.63 | 114,955 (Direct) |
View |
| 2021-07-15 Option Award |
2022-03-18 4:36 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben Chief Operating Officer |
868 | $11.49 | 114,955 (Direct) |
View |
| 2022-03-16 Tax Withholding |
2022-03-18 4:36 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben Chief Operating Officer |
681 | $10.13 | 114,955 (Direct) |
View |
| 2021-10-04 Option Award |
2021-10-06 4:51 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R Chief Accounting Officer |
700 | $0 | 700 (Direct) |
View |
| 2021-09-02 Option Award |
2021-09-07 5:21 pm |
N/A 2031-09-01 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben Chief Business Officer |
54,994 | $0 | 54,994 (Direct) |
View |
| 2021-09-02 Option Award |
2021-09-07 5:20 pm |
N/A 2031-09-01 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R Chief Accounting Officer |
9,293 | $0 | 9,293 (Direct) |
View |
| 2021-09-02 Option Award |
2021-09-07 5:19 pm |
N/A 2031-09-01 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Pano Arian Chief Clinical Dev. Officer |
27,213 | $0 | 27,213 (Direct) |
View |
| 2021-09-02 Option Award |
2021-09-07 5:18 pm |
N/A 2031-09-01 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark Chief Financial Officer |
52,105 | $0 | 52,105 (Direct) |
View |
| 2021-09-02 Option Award |
2021-09-07 5:16 pm |
N/A 2031-09-01 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross ARCALYST General Manager |
11,931 | $0 | 11,931 (Direct) |
View |
| 2021-09-02 Option Award |
2021-09-07 5:15 pm |
N/A 2031-09-01 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. Chief Medical Officer |
48,300 | $0 | 48,300 (Direct) |
View |
| 2021-09-02 Option Award |
2021-09-07 5:14 pm |
N/A 2031-09-01 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K Chairman & CEO |
183,934 | $0 | 183,934 (Direct) |
View |
| 2021-06-29 Option Award |
2021-07-01 4:08 pm |
N/A 2031-06-28 |
Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director |
66,474 | $0 | 66,474 (Indirect) |
View |
| 2021-06-29 Option Award |
2021-06-30 4:22 pm |
N/A 2031-06-28 |
Kiniksa Pharmaceuticals Ltd. | KNSA | McCain Tracey L Director |
33,237 | $0 | 33,237 (Direct) |
View |
| 2021-06-29 Option Award |
2021-06-30 4:22 pm |
N/A 2031-06-28 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Popovits Kimberly J Director |
33,237 | $0 | 33,237 (Direct) |
View |
| 2021-06-29 Option Award |
2021-06-30 4:21 pm |
N/A 2031-06-28 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Malley Thomas Director |
33,237 | $0 | 33,237 (Direct) |
View |
| 2021-06-29 Option Award |
2021-06-30 4:20 pm |
N/A 2031-06-28 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director |
33,237 | $0 | 33,237 (Direct) |
View |
| 2021-06-29 Option Award |
2021-06-30 4:20 pm |
N/A 2031-06-28 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Levy Richard S Director |
33,237 | $0 | 33,237 (Direct) |
View |
| 2021-06-29 Option Award |
2021-06-30 4:20 pm |
N/A 2031-06-28 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Cole G Bradley Director |
33,237 | $0 | 33,237 (Direct) |
View |
Ownership |
2021-06-21 5:37 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Pano Arian Chief Clinical Dev. Officer |
0 | $0 | 196,859 (Direct) |
View |
Ownership |
2021-06-21 5:37 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben Chief Business Officer |
0 | $0 | 622,046 (Direct) |
View |